Corresponding Author: Jennifer A. Blumenthal, MD, Critical Care Medicine and Infectious Diseases, Division of Critical Care Medicine, Boston Children’s Hospital, 300 Longwood Ave, Mail Stop Bader 634, Boston, MA 02115 (jennifer.blumenthal@childrens.harvard.edu).
Published Online: April 6, 2021. doi:10.1001/jamapediatrics.2021.0638
Conflict of Interest Disclosures: None reported.
1.Johns Hopkins University of Medicine Coronavirus Resource Center. COVID-19 dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU). Accessed February 28, 2021.
https://coronavirus.jhu.edu/map.html 2.Leidman
E , Duca
LM , Omura
JD , Proia
K , Stephens
JW , Sauber-Schatz
EK . COVID-19 trends among persons aged 0-24 years: United States, March 1-December 12, 2020.
MMWR Morb Mortal Wkly Rep. 2021;70(3):88-94. doi:
10.15585/mmwr.mm7003e1PubMedGoogle ScholarCrossref 3.Belay
ED , Abrams
J , Oster
ME ,
et al. Trends in geographic and temporal distribution of US children with multisystem inflammatory syndrome during the COVID-19 pandemic.
JAMA Pediatr. Published online April 6, 2021. doi:
10.1001/jamapediatrics.2021.0630Google Scholar 4.Rostad
CA , Chahroudi
A , Mantus
G ,
et al. Quantitative SARS-CoV-2 serology in children with multisystem inflammatory syndrome (MIS-C).
Pediatrics. 2020;146(6):e2020018242. doi:
10.1542/peds.2020-018242Google Scholar 5.Centers for Disease Control and Prevention. Information for healthcare providers about multisystem inflammatory syndrome in children (MIS-C). Accessed February 28, 2021.
https://www.cdc.gov/ mis-c/hcp/ 7.Feldstein
LR , Tenforde
MW , Friedman
KG ,
et al; Overcoming COVID-19 Investigators. Characteristics and outcomes of us children and adolescents with multisystem inflammatory syndrome in children (MIS-C) compared with severe acute COVID-19.
JAMA. 2021;325(11):1074-1087. doi:
10.1001/jama.2021.2091Google ScholarCrossref